Trident Lifeline Reports Strong Growth and Low Debt Amid Market Evaluation Adjustments
Trident Lifeline, a microcap in the Pharmaceuticals & Drugs sector, has recently adjusted its evaluation amid strong financial performance for Q3 FY24-25. The company reported a 43.10% increase in net sales and a 57.52% rise in operating profit, maintaining a low debt-to-equity ratio and consistent growth over three quarters.
Trident Lifeline, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment reflecting its current market dynamics. The company has reported positive financial performance for the third quarter of FY24-25, showcasing a robust annual growth rate in net sales of 43.10% and an impressive operating profit increase of 57.52%. In terms of financial health, Trident Lifeline maintains a low debt-to-equity ratio of 0.24, indicating a conservative approach to leverage. The company has consistently delivered positive results over the last three consecutive quarters, with net sales for the first nine months reaching Rs 46.91 crore, marking a growth of 82.81%. Additionally, the profit after tax for the same period has surged to Rs 9.43 crore, reflecting a significant increase of 123.46%.
The stock's technical indicators suggest a mildly bullish trend, with the Bollinger Band showing bullish signals since early February 2025. Despite a recent return of 32.98% over the past year, Trident Lifeline's valuation metrics indicate it is trading at a discount compared to its historical averages, with a PEG ratio of 0.3.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
